262 related articles for article (PubMed ID: 22851649)
21. The genomic rate of molecular adaptation of the human influenza A virus.
Bhatt S; Holmes EC; Pybus OG
Mol Biol Evol; 2011 Sep; 28(9):2443-51. PubMed ID: 21415025
[TBL] [Abstract][Full Text] [Related]
22. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.
Koel BF; Burke DF; Bestebroer TM; van der Vliet S; Zondag GC; Vervaet G; Skepner E; Lewis NS; Spronken MI; Russell CA; Eropkin MY; Hurt AC; Barr IG; de Jong JC; Rimmelzwaan GF; Osterhaus AD; Fouchier RA; Smith DJ
Science; 2013 Nov; 342(6161):976-9. PubMed ID: 24264991
[TBL] [Abstract][Full Text] [Related]
23. Predictability of antigenic evolution for H3N2 human influenza A virus.
Suzuki Y
Genes Genet Syst; 2013; 88(4):225-32. PubMed ID: 24463525
[TBL] [Abstract][Full Text] [Related]
24. Predominance of influenza A(H3N2) viruses during the 2016/2017 season in Bulgaria.
Korsun N; Angelova S; Trifonova I; Tzotcheva I; Mileva S; Voleva S; Georgieva I; Perenovska P
J Med Microbiol; 2018 Feb; 67(2):228-239. PubMed ID: 29297852
[TBL] [Abstract][Full Text] [Related]
25. Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
Suntronwong N; Klinfueng S; Vichiwattana P; Korkong S; Thongmee T; Vongpunsawad S; Poovorawan Y
PLoS One; 2017; 12(12):e0189511. PubMed ID: 29252990
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.
Al Khatib HA; Al Thani AA; Gallouzi I; Yassine HM
BMC Infect Dis; 2019 Apr; 19(1):314. PubMed ID: 30971204
[TBL] [Abstract][Full Text] [Related]
27. Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation.
Du X; Dong L; Lan Y; Peng Y; Wu A; Zhang Y; Huang W; Wang D; Wang M; Guo Y; Shu Y; Jiang T
Nat Commun; 2012 Feb; 3():709. PubMed ID: 22426230
[TBL] [Abstract][Full Text] [Related]
28. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany.
Wedde M; Biere B; Wolff T; Schweiger B
Int J Med Microbiol; 2015 Oct; 305(7):762-75. PubMed ID: 26416089
[TBL] [Abstract][Full Text] [Related]
29. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
[TBL] [Abstract][Full Text] [Related]
30. Evolution of H3N2 influenza virus in a guinea pig model.
Long J; Bushnell RV; Tobin JK; Pan K; Deem MW; Nara PL; Tobin GJ
PLoS One; 2011; 6(7):e20130. PubMed ID: 21799726
[TBL] [Abstract][Full Text] [Related]
31. Dynamic Convergent Evolution Drives the Passage Adaptation across 48 Years' History of H3N2 Influenza Evolution.
Chen H; Deng Q; Ng SH; Lee RT; Maurer-Stroh S; Zhai W
Mol Biol Evol; 2016 Dec; 33(12):3133-3143. PubMed ID: 27604224
[TBL] [Abstract][Full Text] [Related]
32. Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution.
Du X; Wang Z; Wu A; Song L; Cao Y; Hang H; Jiang T
Genome Res; 2008 Jan; 18(1):178-87. PubMed ID: 18032723
[TBL] [Abstract][Full Text] [Related]
33. Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
Monamele GC; Vernet MA; Njankouo MR; Victoir K; Akoachere JF; Anong D; Njouom R
PLoS One; 2017; 12(9):e0184411. PubMed ID: 28877235
[TBL] [Abstract][Full Text] [Related]
34. Molecular evolution of human influenza A/H3N2 virus in Asia and Europe from 2001 to 2003.
Chi XS; Bolar TV; Zhao P; Tam JS; Rappaport R; Cheng SM
J Clin Microbiol; 2005 Dec; 43(12):6130-2. PubMed ID: 16333111
[TBL] [Abstract][Full Text] [Related]
35. Positive selection for gains of N-linked glycosylation sites in hemagglutinin during evolution of H3N2 human influenza A virus.
Suzuki Y
Genes Genet Syst; 2011; 86(5):287-94. PubMed ID: 22362027
[TBL] [Abstract][Full Text] [Related]
36. Intrasubtype reassortments cause adaptive amino acid replacements in H3N2 influenza genes.
Neverov AD; Lezhnina KV; Kondrashov AS; Bazykin GA
PLoS Genet; 2014 Jan; 10(1):e1004037. PubMed ID: 24415946
[TBL] [Abstract][Full Text] [Related]
37. Role of Substitutions in the Hemagglutinin in the Emergence of the 1968 Pandemic Influenza Virus.
Van Poucke S; Doedt J; Baumann J; Qiu Y; Matrosovich T; Klenk HD; Van Reeth K; Matrosovich M
J Virol; 2015 Dec; 89(23):12211-6. PubMed ID: 26378170
[TBL] [Abstract][Full Text] [Related]
38. Passage Adaptation Correlates With the Reduced Efficacy of the Influenza Vaccine.
Chen H; Alvarez JJS; Ng SH; Nielsen R; Zhai W
Clin Infect Dis; 2019 Sep; 69(7):1198-1204. PubMed ID: 30561532
[TBL] [Abstract][Full Text] [Related]
39. Analysis of antigenically important residues in human influenza A virus in terms of B-cell epitopes.
Lees WD; Moss DS; Shepherd AJ
J Virol; 2011 Sep; 85(17):8548-55. PubMed ID: 21680505
[TBL] [Abstract][Full Text] [Related]
40. Evolutionary study and phylodynamic pattern of human influenza A/H3N2 virus in Indonesia from 2008 to 2010.
Agustiningsih A; Trimarsanto H; Restuadi R; Artika IM; Hellard M; Muljono DH
PLoS One; 2018; 13(8):e0201427. PubMed ID: 30067808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
